Where does Alios Biopharma, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Alios Biopharma, Inc. ranks #7,972 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Alios Biopharma, Inc. hold?

Alios Biopharma, Inc. holds 40 US utility patents granted between 2015 and 2019, spanning 13 technology areas.

What is Alios Biopharma, Inc.'s Innovation Score?

Alios Biopharma, Inc. has an Innovation Score of 40.6 out of 100 (top 35% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Alios Biopharma, Inc. focus on?

Alios Biopharma, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 33 patents, ranking #676 of 7,163 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Alios Biopharma, Inc.'s patent grant rate increasing or decreasing?

Alios Biopharma, Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Alios Biopharma, Inc.'s patents?

Alios Biopharma, Inc.'s patents average 29.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Alios Biopharma, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Alios Biopharma, Inc.

USPTO PatentsView assignee record - 40 granted patents across 13 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Alios ranks #7,972 of 49,997 tracked US assignees by granted-patent volume, with 40 patents across 13 technology areas.

#7,972
of 49,997 US assignees by volume: Top 35%
by Innovation Score (40.6/100): 29.5
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7972 · US Corporation #7,972 · 40 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 40 grants
UPPER-Q #7,972/49,997
PHOTO-FINISH 2266170 Ontario
CPC-FOCUS A61K · 13 areas
INNOV-PAR 40.6/100
CLAIMS-DENSE 29.5 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: 2266170 Ontario Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Alios’s 40.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.8 pts (32%) Velocity 0.0 pts (0%) Breadth 12.7 pts (31%) Claim depth 15.0 pts (37%)

Qualcomm Incorporated · highest

85
Alios Biopharma · this assignee

41
Chang Gung Memorial… · near

41
Christian Dior Couture · near

41
Flint Group Germany · near

41
GeoFrenzy · near

41
3D Lighting… · lowest

7

What this shows Alios's Innovation Score is 40.6/100 (top 35% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Alios?

Each dot is one of Alios’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Alios’s own 29.5 claims/patent is ABOVE the 11.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Alios vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Alios's grants concentrate

Alios Biopharma, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 82.5% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (11 grants) versus a trough of 3 in 2015. By volume, Alios sits between Zhejiang Chint Electrics Co., Ltd. and ARK Therapeutic Services, Inc..

Zhejiang Chint El…

41
Zafgen

41
2266170 Ontario

40
Abbvie Stemcentrx

40
Amcor Rigid Packa…

40
Anchor Hocking

40
AR & NS Investment

40
ARK Therapeutic S…

40
Alios Biopharma ◀

40

What this shows Alios holds 40 patents at rank #7,970, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Alios

By rank, the assignees closest to #7,970 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Alios's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Alios, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Alios ranks #676 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

Chang Gung Memorial Hospital, Linkou 41 Flint Group Germany GmbH 41 GeoFrenzy, Inc. 41 Christian Dior Couture 41

Alios's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 35% higher than 65% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Alios Biopharma, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	7.5%
2016	11	27.5%
2017	7	17.5%
2018	8	20.0%
2019	11	27.5%

Which technologies does Alios Biopharma, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 33

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 33

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 25

C07D - Heterocyclic Compounds 10

Y02A - Technologies FOR Adaptation TO Climate Change 5

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 5

C12Y - Enzymes 4

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 4

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

C07C - Acyclic OR Carbocyclic Compounds 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Alios Biopharma, Inc.'s patent record in context - here's where to go next.

Alios Biopharma, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 82.5% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #7,972 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Alios Biopharma, Inc. against Zhejiang Chint Electrics Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.